Developer docs
API playgroundTry for free, no card

Search company profiles

Institute for Bioscience and Biotechnology Research

Full company profile

uuid0003lyv

Namestring
Institute for Bioscience and Biotechnology Research
Legal namestring
Institute for Bioscience and Biotechnology Research
Websiteurl
ibbr.umd.edu
Company typeenum
Private
Founded yearint
2011
Descriptiontext

The Institute for Bioscience and Biotechnology Research (IBBR) is a joint research enterprise of the University of Maryland College Park, the University of Maryland Baltimore, and the National Institute of Standards and Technology (NIST), established in 2010-2011 at 9600 Gudelsky Drive, Rockville, Maryland. IBBR applies integrative structural biology methods, including cryo-electron microscopy, nuclear magnetic resonance (NMR), X-ray crystallography, small-angle X-ray and neutron scattering, and mass spectrometry, to characterize biomolecules for therapeutic, vaccine, and biomanufacturing applications. The institute also develops and maintains NMRPipe, an open-source NMR data-processing suite cited in roughly 40% of NMR structures in the Protein Data Bank, and operates the IBBR Commons shared-instrumentation facility, the IBBR Postdoc Program, the NIST Biomanufacturing Resource Hub, and the Consortium for Glycoengineering of Advanced Biologics (CGAB).

IBBR serves academic, government, and industry collaborators rather than commercial customers, with research spanning infectious disease (Hepatitis C, Ebola, malaria), plant biotechnology, protein engineering, and biomanufacturing standards. Its 299 members have produced 1,687 publications and mentored 176 post-docs; senior staff include AAAS, ACS, and ASBMB Fellows.

The institute operates as a non-profit research entity, not a commercial enterprise. Funding flows from federal grants (NIH, NIAID, NSF), cooperative agreements with NIST ($2M per year for three years per the 2012 renewal), SBIR collaborations with companies such as Sanaria Inc., and private foundation awards (e.g., $1.2M W.M. Keck Foundation in 2026). IBBR holds no private equity or venture capital; it is administered under the University of Maryland Strategic Partnership: MPowering the State, and pricing does not apply in the conventional sense because it sells no products or services commercially.

Short descriptiontext

IBBR is a non-profit joint research enterprise of UMD College Park, UMD Baltimore, and NIST, applying cryo-EM, NMR, X-ray crystallography, SAXS, and mass spectrometry to advance therapeutics, vaccines, biomanufacturing, and measurement standards for academic, government, and industry collaborators.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersRockville, United States
HQ citystring
Rockville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
structural biology research, biopharmaceutical development, biophysical characterization, vaccine development, biomanufacturing services
Industry2 codes
PRIMARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biotechnology Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Federal Research Grants
TypeOthers
Description

IBBR receives funding from NIH, NIAID, NSF, and other federal agencies for specific research programs. Examples include $6.9M NIAID grant for Hepatitis C vaccine development and $1.2M Keck Foundation award.

ibbr.umd.edu
2Cooperative Agreements
TypeOthers
Description

IBBR operates under cooperative agreements with NIST providing $2M per year for three years for interdisciplinary life sciences research.

ibbr.umd.edu
3Small Business Innovation Research (SBIR) Grants
TypeOthers
Description

Collaborative grants with private companies like Sanaria Inc. for joint research projects, such as the $3M NIH Phase II SBIR for malaria vaccine development.

ibbr.umd.edu
4Foundation Awards
TypeLicensing Royalties
Description

Private foundation funding such as $1.2M W.M. Keck Foundation award for metamorphic proteins research.

ibbr.umd.edu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1IBBR Commons
Description

Sophisticated state-of-the-art instrumentation and facilities, and in-house expertise located in shared space dedicated to advance research, support collaboration and foster innovation of methods.

ibbr.umd.edu
+3 more records
Core offering1 text field

IBBR is a joint research enterprise of the University of Maryland and NIST that conducts integrative bioanalytical, biophysical and structural characterization research on biomolecules. It provides shared access to state-of-the-art instrumentation (NMR, cryoEM, mass spectrometry, X-ray crystallography), operates the NMRPipe NMR data processing software, runs a postdoctoral training program, and manages the NIST Biomanufacturing Resource Hub and the Consortium for Glycoengineering of Advanced Biologics (CGAB). The institute advances therapeutic development, vaccine research, biomanufacturing, and measurement science through collaborative research programs funded by federal grants and partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 1687 publications as listed on IBBR website
+2 more records
Product overview1 text field

IBBR is a joint research enterprise of the University of Maryland, College Park, the University of Maryland, Baltimore, and the National Institute of Standards and Technology. Rather than a commercial product company, IBBR operates as a research institute providing shared research facilities, instrumentation services, and educational programs. Its core offerings include IBBR Commons (shared state-of-the-art instrumentation and facilities), NMRPipe (NMR data processing software), the Postdoc Program (IPP), the Consortium for Glycoengineering of Advanced Biologics (CGAB), and the NIST Biomanufacturing Resource Hub. The institute focuses on advancing therapeutic development, vaccine development, biomanufacturing, and state-of-the-art measurement technologies.

Product and service6 records
1NMRPipe
CategoryResearch Software
Description

A popular collection of programs and scripts for manipulating multidimensional Nuclear Magnetic Resonance (NMR) data, used in roughly 40% of all NMR structures accepted into the Protein Data Bank. Available to the structural biology research community.

2IBBR Commons
CategoryShared Research Facility
Description

Shared state-of-the-art instrumentation and facilities with in-house expertise dedicated to advance research, support collaboration and foster innovation of methods. Includes tools for high-resolution structural biology, bioanalytical and biophysical measurement, protein engineering and cell culture, advanced computation including AI/deep learning, and general laboratory services. Available to IBBR scientists and collaborators.

3Consortium for Glycoengineering of Advanced Biologics (CGAB)
CategoryResearch Consortium
Description

A consortium focused on glycoengineering of advanced biologics, representing IBBR's newest research consortium initiative. Provides collaborative research framework for industry and academic partners.

4NIST Biomanufacturing Resource Hub
CategoryResearch Resource/Service
Description

A resource hub providing biomanufacturing support and resources, operated in partnership with NIST.

5IBBR Postdoc Program (IPP)
CategoryEducation/Training Program
Description

A postdoctoral program focusing on collaborative research involving basic science and technology development that advances therapeutic development, vaccine development, and biomanufacturing. IPP Fellow project teams are designed with a combination of career goals and priorities of project mentors from academic, government, and/or industrial laboratories throughout the University of Maryland, NIST and the I-270 corridor.

6Insect Transformation Facility
CategoryResearch Service Facility
Description

International resource for the creation of genetically modified insects for academic and industrial clients. Used in collaborative projects such as malaria vaccine development with Sanaria Inc.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2012-06-19
Description

Collaborative partnership for malaria vaccine development. Sanaria Inc., a privately held company in Rockville, Maryland, partnered with IBBR on a $3 million NIH Phase II SBIR grant to genetically engineer mosquitoes that produce large numbers of parasites for malaria vaccine manufacturing.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborators on W.M. Keck Foundation metamorphic proteins research project

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborators on W.M. Keck Foundation metamorphic proteins research project

Strategic tierMinorTypeStrategic or Co-development Partner
Description

TACF funds and collaborates on chestnut tree restoration research. Graduate student Bruce Levine's work is funded by TACF and he is active in TACF's chestnut breeding program in Maryland.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of three founding institutions of IBBR. UMD provides research facilities, faculty, and students to the joint research enterprise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of three founding institutions of IBBR. UMB provides research facilities, faculty, and students to the joint research enterprise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of three founding institutions. NIST provides state-of-the-art resources and equipment including the 900 MHz NMR spectrometer and supports cooperative agreements. Partnership spans 25+ years.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-PI on NSF Plant Genome Research Program grant (IOS-2224203-2224205) for nonhost resistance mechanisms in plants

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-PI on NSF Plant Genome Research Program grant for nonhost resistance mechanisms in plants

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DOE national laboratory operating the Advanced Light Source synchrotron and major cryo-EM facilities used for protein structure determination. Comparable as a federally funded research center providing shared-access analytical instrumentation for life sciences.

TypeOthers
Description

Federal agency that is one of IBBR's three founding institutions and the operator of the cooperative agreement providing $2M/year. Directly comparable in mission as a measurement-science and standards organization supporting life sciences research and biomanufacturing.

TypeDirect peer
Description

U.S. Department of Energy national laboratory with major structural biology facilities including cryo-EM and synchrotron beamlines used for protein characterization. Operates as a federally funded research center comparable in mission to IBBR's joint UMD-NIST research enterprise model.

TypeDirect peer
Description

MIT-affiliated nonprofit biomedical research institute with leading programs in structural biology, proteomics, and therapeutic development. Comparable as a research-intensive institute with similar headcount scale and mission focus.

TypeDirect peer
Description

Independent, nonprofit biomedical research institute with deep expertise in structural biology, chemistry, and biophysics. Comparable as a research enterprise focused on therapeutic development, vaccine research, and analytical/structural characterization of biomolecules.

TypeDirect peer
Description

Joint research enterprise of MIT, Harvard, and Harvard-affiliated hospitals operating with a model parallel to IBBR's UMD-NIST partnership. Comparable focus on genomics, structural biology, computational biology, and chemical biophysics at scale.

TypeDirect peer
Description

Consortium-operated research facility providing high-field NMRs, cryo-EM, and other structural biology instrumentation to academic and industry users. Directly comparable to IBBR Commons in operating a shared-access structural biology facility for collaborators.

TypeDirect peer
Description

Howard Hughes Medical Institute's research campus focused on structural biology, neuroscience, and tool development with state-of-the-art imaging and computational infrastructure. Comparable as a research-intensive campus emphasizing instrumentation, collaborative science, and high-impact publications.

TypeDirect peer
Description

Independent research institute focused on structural biology with high-field NMR and X-ray crystallography capabilities. Comparable as a smaller research institute operating advanced analytical instrumentation for biomolecular characterization.

TypeRegional player
Description

Federally funded research and development center operated by NIST-affiliated contractor for NIH/NCI, located in Frederick, Maryland. Comparable as a federally chartered research center in the same region focused on biomedical and biopharmaceutical research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Institute for Bioscience and Biotechnology Research

Biotechnology Research Servicesibbr.umd.edu

IBBR is a non-profit joint research enterprise of UMD College Park, UMD Baltimore, and NIST, applying cryo-EM, NMR, X-ray crystallography, SAXS, and mass spectrometry to advance therapeutics, vaccines, biomanufacturing, and measurement standards for academic, government, and industry collaborators.

What Institute for Bioscience and Biotechnology Research does

The Institute for Bioscience and Biotechnology Research (IBBR) is a joint research enterprise of the University of Maryland College Park, the University of Maryland Baltimore, and the National Institute of Standards and Technology (NIST), established in 2010-2011 at 9600 Gudelsky Drive, Rockville, Maryland. IBBR applies integrative structural biology methods, including cryo-electron microscopy, nuclear magnetic resonance (NMR), X-ray crystallography, small-angle X-ray and neutron scattering, and mass spectrometry, to characterize biomolecules for therapeutic, vaccine, and biomanufacturing applications. The institute also develops and maintains NMRPipe, an open-source NMR data-processing suite cited in roughly 40% of NMR structures in the Protein Data Bank, and operates the IBBR Commons shared-instrumentation facility, the IBBR Postdoc Program, the NIST Biomanufacturing Resource Hub, and the Consortium for Glycoengineering of Advanced Biologics (CGAB).

IBBR serves academic, government, and industry collaborators rather than commercial customers, with research spanning infectious disease (Hepatitis C, Ebola, malaria), plant biotechnology, protein engineering, and biomanufacturing standards. Its 299 members have produced 1,687 publications and mentored 176 post-docs; senior staff include AAAS, ACS, and ASBMB Fellows.

The institute operates as a non-profit research entity, not a commercial enterprise. Funding flows from federal grants (NIH, NIAID, NSF), cooperative agreements with NIST ($2M per year for three years per the 2012 renewal), SBIR collaborations with companies such as Sanaria Inc., and private foundation awards (e.g., $1.2M W.M. Keck Foundation in 2026). IBBR holds no private equity or venture capital; it is administered under the University of Maryland Strategic Partnership: MPowering the State, and pricing does not apply in the conventional sense because it sells no products or services commercially.

Institute for Bioscience and Biotechnology Research firmographics

Firmographics
Name
Institute for Bioscience and Biotechnology Research
Legal name
Institute for Bioscience and Biotechnology Research
Website
https://ibbr.umd.edu
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
IBBR is a non-profit joint research enterprise of UMD College Park, UMD Baltimore, and NIST, applying cryo-EM, NMR, X-ray crystallography, SAXS, and mass spectrometry to advance therapeutics, vaccines, biomanufacturing, and measurement standards for academic, government, and industry collaborators.
Ownership category
akta.pro rank

Institute for Bioscience and Biotechnology Research industry classification

Industry
Product category
Biotechnology Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)

Keywords

  • Structural biology research
  • Biopharmaceutical development
  • Biophysical characterization
  • Vaccine development
  • Biomanufacturing services

Where Institute for Bioscience and Biotechnology Research is headquartered

Location

Headquarters

HQ city
Rockville
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Institute for Bioscience and Biotechnology Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

  1. Federal Research Grants: IBBR receives funding from NIH, NIAID, NSF, and other federal agencies for specific research programs. Examples include $6.9M NIAID grant for Hepatitis C vaccine development and $1.2M Keck Foundation award.
  2. Cooperative Agreements: IBBR operates under cooperative agreements with NIST providing $2M per year for three years for interdisciplinary life sciences research.
  3. Small Business Innovation Research (SBIR) Grants: Collaborative grants with private companies like Sanaria Inc. for joint research projects, such as the $3M NIH Phase II SBIR for malaria vaccine development.
  4. Foundation Awards: Private foundation funding such as $1.2M W.M. Keck Foundation award for metamorphic proteins research.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Institute for Bioscience and Biotechnology Research product offering

Product offering

Core offering

IBBR is a joint research enterprise of the University of Maryland and NIST that conducts integrative bioanalytical, biophysical and structural characterization research on biomolecules. It provides shared access to state-of-the-art instrumentation (NMR, cryoEM, mass spectrometry, X-ray crystallography), operates the NMRPipe NMR data processing software, runs a postdoctoral training program, and manages the NIST Biomanufacturing Resource Hub and the Consortium for Glycoengineering of Advanced Biologics (CGAB). The institute advances therapeutic development, vaccine research, biomanufacturing, and measurement science through collaborative research programs funded by federal grants and partnerships.

Product overview

IBBR is a joint research enterprise of the University of Maryland, College Park, the University of Maryland, Baltimore, and the National Institute of Standards and Technology. Rather than a commercial product company, IBBR operates as a research institute providing shared research facilities, instrumentation services, and educational programs. Its core offerings include IBBR Commons (shared state-of-the-art instrumentation and facilities), NMRPipe (NMR data processing software), the Postdoc Program (IPP), the Consortium for Glycoengineering of Advanced Biologics (CGAB), and the NIST Biomanufacturing Resource Hub. The institute focuses on advancing therapeutic development, vaccine development, biomanufacturing, and state-of-the-art measurement technologies.

Differentiator

Problem solved

Functional benefit

Brands

  • IBBR Commons: Sophisticated state-of-the-art instrumentation and facilities, and in-house expertise located in shared space dedicated to advance research, support collaboration and foster innovation of methods.
  • IBBR Postdoc Program (IPP)
  • NMRPipe
  • Consortium for Glycoengineering of Advanced Biologics (CGAB)

Products and services

  • NMRPipe A popular collection of programs and scripts for manipulating multidimensional Nuclear Magnetic Resonance (NMR) data, used in roughly 40% of all NMR structures accepted into the Protein Data Bank. Available to the structural biology research community.
  • IBBR Commons Shared state-of-the-art instrumentation and facilities with in-house expertise dedicated to advance research, support collaboration and foster innovation of methods. Includes tools for high-resolution structural biology, bioanalytical and biophysical measurement, protein engineering and cell culture, advanced computation including AI/deep learning, and general laboratory services. Available to IBBR scientists and collaborators.
  • Consortium for Glycoengineering of Advanced Biologics (CGAB) A consortium focused on glycoengineering of advanced biologics, representing IBBR's newest research consortium initiative. Provides collaborative research framework for industry and academic partners.
  • NIST Biomanufacturing Resource Hub A resource hub providing biomanufacturing support and resources, operated in partnership with NIST.
  • IBBR Postdoc Program (IPP) A postdoctoral program focusing on collaborative research involving basic science and technology development that advances therapeutic development, vaccine development, and biomanufacturing. IPP Fellow project teams are designed with a combination of career goals and priorities of project mentors from academic, government, and/or industrial laboratories throughout the University of Maryland, NIST and the I-270 corridor.
  • Insect Transformation Facility International resource for the creation of genetically modified insects for academic and industrial clients. Used in collaborative projects such as malaria vaccine development with Sanaria Inc.

Quantifiable outcome

  • 1687 publications as listed on IBBR website
  • +2 more outcomes

Companies that use Institute for Bioscience and Biotechnology Research

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Institute for Bioscience and Biotechnology Research technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Institute for Bioscience and Biotechnology Research partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Sanaria Inc.coreStrategic or Co-development Partner · 19 June 2012Collaborative partnership for malaria vaccine development. Sanaria Inc., a privately held company in Rockville, Maryland, partnered with IBBR on a $3 million NIH Phase II SBIR grant to genetically engineer mosquitoes that produce large numbers of parasites for malaria vaccine manufacturing.
  • UC-MercedminorStrategic or Co-development PartnerCollaborators on W.M. Keck Foundation metamorphic proteins research project
  • CaltechminorStrategic or Co-development PartnerCollaborators on W.M. Keck Foundation metamorphic proteins research project
  • The American Chestnut Foundation (TACF)minorStrategic or Co-development PartnerTACF funds and collaborates on chestnut tree restoration research. Graduate student Bruce Levine's work is funded by TACF and he is active in TACF's chestnut breeding program in Maryland.
  • University of Maryland, College ParkcoreStrategic or Co-development PartnerOne of three founding institutions of IBBR. UMD provides research facilities, faculty, and students to the joint research enterprise.
  • University of Maryland, BaltimorecoreStrategic or Co-development PartnerOne of three founding institutions of IBBR. UMB provides research facilities, faculty, and students to the joint research enterprise.
  • National Institute of Standards and Technology (NIST)coreStrategic or Co-development PartnerOne of three founding institutions. NIST provides state-of-the-art resources and equipment including the 900 MHz NMR spectrometer and supports cooperative agreements. Partnership spans 25+ years.
  • University of Missouri (Bing Yang)minorStrategic or Co-development PartnerCo-PI on NSF Plant Genome Research Program grant (IOS-2224203-2224205) for nonhost resistance mechanisms in plants
  • Howard University (Hemayet Ullah)minorStrategic or Co-development PartnerCo-PI on NSF Plant Genome Research Program grant for nonhost resistance mechanisms in plants

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Institute for Bioscience and Biotechnology Research competitors and assessment

Company assessment

Direct peers

  • Lawrence Berkeley National Laboratory: DOE national laboratory operating the Advanced Light Source synchrotron and major cryo-EM facilities used for protein structure determination. Comparable as a federally funded research center providing shared-access analytical instrumentation for life sciences.
  • Brookhaven National Laboratory: U.S. Department of Energy national laboratory with major structural biology facilities including cryo-EM and synchrotron beamlines used for protein characterization. Operates as a federally funded research center comparable in mission to IBBR's joint UMD-NIST research enterprise model.
  • Whitehead Institute for Biomedical Research: MIT-affiliated nonprofit biomedical research institute with leading programs in structural biology, proteomics, and therapeutic development. Comparable as a research-intensive institute with similar headcount scale and mission focus.
  • The Scripps Research Institute: Independent, nonprofit biomedical research institute with deep expertise in structural biology, chemistry, and biophysics. Comparable as a research enterprise focused on therapeutic development, vaccine research, and analytical/structural characterization of biomolecules.
  • Broad Institute: Joint research enterprise of MIT, Harvard, and Harvard-affiliated hospitals operating with a model parallel to IBBR's UMD-NIST partnership. Comparable focus on genomics, structural biology, computational biology, and chemical biophysics at scale.
  • New York Structural Biology Center: Consortium-operated research facility providing high-field NMRs, cryo-EM, and other structural biology instrumentation to academic and industry users. Directly comparable to IBBR Commons in operating a shared-access structural biology facility for collaborators.
  • Janelia Research Campus (HHMI): Howard Hughes Medical Institute's research campus focused on structural biology, neuroscience, and tool development with state-of-the-art imaging and computational infrastructure. Comparable as a research-intensive campus emphasizing instrumentation, collaborative science, and high-impact publications.
  • Hauptman-Woodward Medical Research Institute: Independent research institute focused on structural biology with high-field NMR and X-ray crystallography capabilities. Comparable as a smaller research institute operating advanced analytical instrumentation for biomolecular characterization.

Others

  • National Institute of Standards and Technology (NIST): Federal agency that is one of IBBR's three founding institutions and the operator of the cooperative agreement providing $2M/year. Directly comparable in mission as a measurement-science and standards organization supporting life sciences research and biomanufacturing.

Regional players

  • Frederick National Laboratory for Cancer Research: Federally funded research and development center operated by NIST-affiliated contractor for NIH/NCI, located in Frederick, Maryland. Comparable as a federally chartered research center in the same region focused on biomedical and biopharmaceutical research.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Institute for Bioscience and Biotechnology Research social profiles

Digital presence

Institute for Bioscience and Biotechnology Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Institute for Bioscience and Biotechnology Research leadership team

Management profile

Number of profiles

Profiles4 records

Institute for Bioscience and Biotechnology Research funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Institute for Bioscience and Biotechnology Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Bioscience and Biotechnology Research

What does Institute for Bioscience and Biotechnology Research do?

IBBR is a joint research enterprise of the University of Maryland and NIST that conducts integrative bioanalytical, biophysical and structural characterization research on biomolecules. It provides shared access to state-of-the-art instrumentation (NMR, cryoEM, mass spectrometry, X-ray crystallography), operates the NMRPipe NMR data processing software, runs a postdoctoral training program, and manages the NIST Biomanufacturing Resource Hub and the Consortium for Glycoengineering of Advanced Biologics (CGAB). The institute advances therapeutic development, vaccine research, biomanufacturing, and measurement science through collaborative research programs funded by federal grants and partnerships.

Is Institute for Bioscience and Biotechnology Research a public or private company?

Institute for Bioscience and Biotechnology Research is a private company. It is classified as state government owned and is currently operating.

When was Institute for Bioscience and Biotechnology Research founded?

Institute for Bioscience and Biotechnology Research was founded in 2011. It employs 101 to 250 people.

Where is Institute for Bioscience and Biotechnology Research based?

Institute for Bioscience and Biotechnology Research is headquartered in Rockville, United States, in the North America region.

How does Institute for Bioscience and Biotechnology Research make money?

Four revenue lines are on record. Federal Research Grants are the primary driver. The others are cooperative Agreements, small Business Innovation Research (SBIR) Grants and foundation Awards.

Who are Institute for Bioscience and Biotechnology Research's main competitors?

Direct peers on record are Lawrence Berkeley National Laboratory, Brookhaven National Laboratory, Whitehead Institute for Biomedical Research, The Scripps Research Institute, Broad Institute, New York Structural Biology Center, Janelia Research Campus (HHMI) and Hauptman-Woodward Medical Research Institute. National Institute of Standards and Technology (NIST) is listed as an others. Frederick National Laboratory for Cancer Research is listed as a regional player.

Does Institute for Bioscience and Biotechnology Research have an API?

No public API is recorded for Institute for Bioscience and Biotechnology Research.

What industry is Institute for Bioscience and Biotechnology Research in?

Institute for Bioscience and Biotechnology Research's product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAGADAA, Bioanalytical Testing (PK/ADA/NAb), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireInstitute for Bioscience and Biotechnology Research Awarded $6.9M to Design and Test a Vaccine to Combat Hepatitis CThe National Institute of Allergy and Infectious Disease (NIAID) awarded a $6.9 million grant to the Institute for Bioscience and Biotechnology Research (IBBR) to design and test a vaccine for Hepatitis C. This five-year funding supports a multi-disciplinary team from the University of Maryland and Princeton University in developing broadly neutralizing antibodies to prevent HCV infection. The award serves as a follow-on to previous research grants aimed at addressing the global burden of the disease.PR NewswireInstitute for Bioscience and Biotechnology Research Receives $16.8 M Investment from the National Institute of Standards and TechnologyThe Institute for Bioscience and Biotechnology Research (IBBR) has secured a five-year, $16.8 million cooperative agreement with the National Institute of Standards and Technology (NIST). This funding will support research into vaccine and therapeutic discovery, including mRNA vaccines and cell therapies, while providing advanced instrumentation for the IBBR Commons.PR NewswireIBBR Researchers Awarded $850K from NSF to Study How Plants Defend Against Fungal InvasionResearchers at the Institute for Bioscience and Biotechnology Research (IBBR) have been awarded $850,000 by the National Science Foundation to study how plants defend against fungal pathogens like powdery mildew. Led by Dr. Shunyuan Xiao, the project aims to identify proteins at the host-pathogen interface to develop new strategies for controlling crop diseases and improving global food security.PR NewswireIBBR Request for Proposals (RFP): GMP Biomanufacturing Facility Available - Rockville, Maryland, USAThe Institute for Bioscience and Biotechnology Research (IBBR) issued a Request for Proposals to lease its cGMP biomanufacturing facility in Rockville, Maryland, configured for Phase I/II clinical trial production under FDA requirements. The approximately 9,100 square foot facility supports bacterial, yeast, and mammalian cell culture for therapeutic proteins, CAR-T cell therapies, monoclonal antibodies, vaccines, and other biological products. IBBR, a joint research enterprise of the University of Maryland and NIST, will evaluate proposals on a rolling basis based on applicant qualifications, proposed rental rates, collaboration type, and economic development impact.PR NewswireFighting Acne: A New Approach Sourced From VirusesThe Institute for Bioscience and Biotechnology Research (IBBR) received a Technology Assessment award from the Maryland Innovation Initiative (MII), part of TEDCO's Innovation Commercialization Program, to fund a new phage-based approach to treating acne vulgaris. IBBR Fellow Dr. Daniel Nelson will lead the project, which leverages endolysins—proteins produced by bacteriophages that can kill Cutibacterium acnes bacteria on contact within seconds. The funding will support laboratory characterization of C. acnes-specific endolysins, development of delivery formulas, and initial safety and efficacy assessments, with the goal of creating the first directly-lytic agent (DLA) acne treatment.PR NewswireIBBR Request for Proposals (RFP): GMP Biomanufacturing Facility Available - Rockville, Maryland, USAThe Institute for Bioscience and Biotechnology Research (IBBR) issued a Request for Proposals to lease its GMP biomanufacturing facility in Rockville, Maryland, with proposals due by September 30, 2019. The approximately 9,100 square foot facility is configured for bacterial/yeast fermentation and mammalian cell culture to manufacture biologicals including therapeutic proteins, CAR-T cell therapies, monoclonal antibodies, vaccines, and other products for Phase I/II clinical trials under FDA cGMP requirements. IBBR, a joint research enterprise between the University of Maryland and the National Institute of Standards and Technology, will evaluate proposals based on applicant qualifications, rental rates, collaboration type, and economic development impact.PR NewswireIBBR Researchers Awarded $1M from DTRA to Develop Portable Medical SensorsResearchers at the Institute for Bioscience and Biotechnology Research (IBBR) received a $1M grant from the Defense Threat Reduction Agency (DTRA) to develop wearable sensors that measure biochemical information for disease diagnosis. The research focuses on redox-based bio-electronic communication, aiming to create portable devices capable of determining a person's health status quickly in settings ranging from physician's offices to battlefields. The project is an ongoing collaboration between IBBR, the Fischell Institute for Biomedical Devices, and researchers at the Naval and Army Research Laboratories.PR NewswireIBBR awarded NIH grant to investigate T cell biology toward development of biotherapeuticsThe Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh have received a $3.6 million NIH grant to characterize LAG3, an immune checkpoint receptor on T cells implicated in cancer and chronic infections like malaria and HIV. IBBR Fellow Dr. Roy Mariuzza and collaborator Dr. Dario Vignali will determine the 3D structure of LAG3 to support development of new biotherapeutics that can inhibit or activate this immune checkpoint molecule. The research complements IBBR's expanding T cell program focused on structural biology and computational modeling tools for TCR-based therapies.PR NewswireIBBR investigator to lead $3.9M NIH-funded project to develop next generation HIV-1 immunotherapy agentsThe Institute for Bioscience and Biotechnology Research (IBBR) has secured a $3.9 million grant from the National Institutes of Health (NIH) to develop next-generation immunotherapy agents against HIV-1. Led by Dr. Yuxing Li, the project aims to create multi-specific antibody therapeutics capable of clearing viral reservoirs that current antiretroviral treatments cannot eliminate. The initiative seeks to advance basic understanding of protective immunity and contribute to strategies for HIV remission and potential eradication.PR NewswireIBBR Receives $1.2M NIH Award to Develop 3D Modeling Tool That Could Lead to New ImmunotherapiesThe Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $1.2 million grant from the National Institutes of Health (NIH) to develop a modeling framework that predicts T cell receptor (TCR) structures and models antigen recognition. Led by principal investigator Dr. Brian Pierce, the project will enhance the existing TCRmodel web server to design new TCRs with targeting capabilities for cancer and other disease immunotherapies. The research is a collaborative effort with experimental laboratories to validate computational approaches, with the goal of advancing cell-based immunotherapies described as the next frontier of cancer treatment.